Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2021-04-01 | Dr. Berendt's experience in the pharmaceutical industry, both from a management and a scientific perspective, provides unique technical insight to the Waters Board. |
Data sourced from SEC filings. Last updated: 2025-10-11